Daily Coverage on Healthcare Stocks ProMIS Neurosciences Spectral Medical GeneNews and Sernova

LONDON, UK / ACCESSWIRE / October 9, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Medical Diagnostics & Research industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: ProMIS Neurosciences, Spectral Medical, GeneNews, and Sernova. Register for these free reports at:

http://protraderdaily.com/register/

On Friday, October 06, 2017, the Toronto Exchange Composite Index was down 0.30%, finishing the day at 15,728.32. The TSX Venture Composite Index, on the other hand, closed at 788.32, up 0.45%.

The Healthcare Index was in the red, closing the day at 68.85, down 0.56%.

Pro-Trader Daily's complimentary research reports on the following stocks are now available: ProMIS Neurosciences Inc. (TSX: PMN), Spectral Medical Inc. (TSX: EDT), GeneNews Ltd (TSX: GEN), and Sernova Corporation (TSXV: SVA). Sign up now for your free membership and research reports at:

http://protraderdaily.com/register/

ProMIS Neurosciences Inc.

Toronto, Canada headquartered ProMIS Neurosciences Inc.'s stock advanced 4.26%, to finish Friday's session at $0.25 with a total volume of 98,850 shares traded. Over the last one month and the previous three months, ProMIS Neurosciences' shares have gained 19.05% and 4.17%, respectively. Furthermore, the stock has rallied 92.31% in the past one year. Shares of the Company, which discovers and develops precision medicine therapeutics for the treatment of neurodegenerative diseases, primarily Alzheimer's disease and amyotrophic lateral sclerosis, are trading above its 50-day moving averages. ProMIS Neurosciences' 200-day moving average of $0.26 is above its 50-day moving average of $0.24. See our research report on PMN.TO at:

http://protraderdaily.com/optin/?symbol=PMN

Spectral Medical Inc.

On Friday, shares in Toronto, Canada headquartered Spectral Medical Inc. recorded a trading volume of 24,193 shares. The stock ended the day 5.68% lower at $0.42. Spectral Medical's stock has gained 6.41% in the last one month and 31.74% in the previous one year. Shares of the Company, which focuses on the development and commercialization of theranostic treatment for septic shock in North America, are trading above its 50-day moving average. The stock's 200-day moving average of $0.45 is above its 50-day moving average of $0.39. The complementary research report on EDT.TO at:

http://protraderdaily.com/optin/?symbol=EDT

GeneNews Ltd

On Friday, shares in Markham, Canada-based GeneNews Ltd ended the session 5.56% higher at $0.10 with a total volume of 78,500 shares traded. Shares of the Company, which focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications, are trading below its 50-day and 200-day moving averages. Furthermore, the stock's 200-day moving average of $0.20 is greater than its 50-day moving average of $0.11. Register for free and access the latest research report on GEN.TO at:

http://protraderdaily.com/optin/?symbol=GEN

Sernova Corp.

London, Canada headquartered Sernova Corp.'s stock closed the day flat at $0.19. The stock recorded a trading volume of 99,500 shares. Shares of the Company, which engages in the research and development of its proprietary Cell Pouch and associated technologies, including immune-protected therapeutic cells, are trading below their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $0.22 is greater than its 50-day moving average of $0.20. Get free access to your research report on SVA.V at:

http://protraderdaily.com/optin/?symbol=SVA

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily